| |
Company
Roster
|
|
Total
Insiders : |
31 |
|
|
|
Total
Direct Shares :
|
29,043,737 |
|
|
Total
Indirect Shares :
|
138,489,441 |
| |
%
Held by Insiders:
|
72.46% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Schaber Christopher |
|
2022-05-18 |
90,095 |
|
0 |
| Straube Richard |
|
2022-05-18 |
8,000 |
|
0 |
| Guarino Jonathan L. |
Senior Vice President and CFO |
2021-12-15 |
11,000 |
2021-12-14 |
0 |
| Zeldis Jerome B |
Director |
2021-05-14 |
22,917 |
2013-06-20 |
0 |
| Parks Diane L. |
Director |
2019-09-23 |
14,940 |
2019-09-23 |
0 |
| Pearson Mark E. |
Director, 10% Owner |
2019-06-28 |
2,500,000 |
2019-06-28 |
78,338 |
| Cavazza Preta Martina |
Former 10% Owner |
2017-11-29 |
293,510 |
2017-11-29 |
0 |
| Rubin Robert Joseph |
Director |
2016-12-16 |
4,385 |
2010-06-18 |
0 |
| Brughera Marco Maria |
Director |
2016-12-16 |
2,750 |
2014-08-05 |
0 |
| Krumeich Karen R |
Officer |
2016-06-16 |
13,000 |
|
0 |
| Lapointe Gregg Anthony |
Director |
2015-08-31 |
73,781 |
2010-06-18 |
0 |
| Brownlie Keith L |
Director |
2015-04-09 |
50,000 |
2013-06-25 |
0 |
| Warusz Joseph Michael |
VP of Finance/Acting CFO |
2014-12-22 |
12,955 |
2014-05-19 |
0 |
| Mintz Hal |
10% Owner |
2010-08-18 |
0 |
2010-08-18 |
21,573,778 |
| Cavazza Paolo |
10% Owner |
2010-06-18 |
1,190,770 |
2010-06-18 |
3,282,929 |
| Biotex Pharma Investments, Llc |
10% Owner |
2009-10-09 |
17,665,000 |
|
0 |
| Myrianthopoulos Evan |
Chief Financial Officer, Director |
2007-08-29 |
224,780 |
2006-04-10 |
0 |
| Clavijo James |
Controller/Treasurer |
2007-08-28 |
88,191 |
2007-02-09 |
0 |
| Buhrman Cyrille F |
Director |
2007-06-28 |
4,900,020 |
|
0 |
| Kanzer Steve H |
Director |
2007-02-09 |
1,282,203 |
2003-09-15 |
125,628 |
| Sember Michael T |
Chief Executive Officer, Director |
2006-04-10 |
180,440 |
2006-04-10 |
0 |
| Rosenwald Lindsay A Md |
10% Owner |
2004-02-12 |
0 |
2004-02-12 |
3,230,922 |
| Elan Pharmaceutical Investments Ii Ltd |
10% Owner |
2004-02-11 |
0 |
2004-02-12 |
1,468,900 |
| Salomon Peter |
Director |
2002-12-31 |
415,000 |
2002-12-31 |
0 |
| Elan Pharmaceutical Investments Ltd |
10% Owner |
2002-10-21 |
0 |
2004-02-13 |
162,600 |
| Cavazza Claudio |
10% Owner |
|
0 |
2010-06-18 |
54,227,816 |
| Brey Robert N |
|
|
0 |
|
0 |
| Donini Oreola |
|
|
0 |
|
0 |
| Cote Timothy R. |
|
|
0 |
2023-05-03 |
25,317 |
| Sigma-Tau Pharmaceuticals, Inc. |
10% Owner |
|
0 |
2010-06-18 |
54,227,816 |
| Intrexon Corp |
10% Owner |
|
0 |
2017-05-08 |
85,397 |
|
